169 related articles for article (PubMed ID: 17545675)
1. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats.
Ro Y; Hamada C; Inaba M; Io H; Kaneko K; Tomino Y
Nephrol Dial Transplant; 2007 Oct; 22(10):2838-48. PubMed ID: 17545675
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-β, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis.
Saglam F; Cavdar Z; Sarioglu S; Kolatan E; Oktay G; Yilmaz O; Camsari T
Ren Fail; 2012; 34(1):95-102. PubMed ID: 22136281
[TBL] [Abstract][Full Text] [Related]
3. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
4. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models.
Io H; Hamada C; Ro Y; Ito Y; Hirahara I; Tomino Y
Kidney Int; 2004 May; 65(5):1927-36. PubMed ID: 15086936
[TBL] [Abstract][Full Text] [Related]
5. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
6. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats.
Hirahara I; Ogawa Y; Kusano E; Asano Y
Nephrol Dial Transplant; 2004 Jul; 19(7):1732-41. PubMed ID: 15128883
[TBL] [Abstract][Full Text] [Related]
7. Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats.
Kushiyama T; Oda T; Yamada M; Higashi K; Yamamoto K; Oshima N; Sakurai Y; Miura S; Kumagai H
Nephrol Dial Transplant; 2011 Oct; 26(10):3143-54. PubMed ID: 21362737
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.
Takahashi S; Taniguchi Y; Nakashima A; Arakawa T; Kawai T; Doi S; Ito T; Masaki T; Kohno N; Yorioka N
Nephron Exp Nephrol; 2009; 112(2):e59-69. PubMed ID: 19390220
[TBL] [Abstract][Full Text] [Related]
10. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum.
Higuchi C; Tanihata Y; Nishimura H; Naito T; Sanaka T
Ther Apher Dial; 2005 Apr; 9(2):173-81. PubMed ID: 15828931
[TBL] [Abstract][Full Text] [Related]
12. Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis.
Kim KH; Ryu HM; Oh SH; Oh EJ; Ahn JS; Lee JH; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Ther Apher Dial; 2014 Dec; 18(6):628-36. PubMed ID: 25256793
[TBL] [Abstract][Full Text] [Related]
13. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
[TBL] [Abstract][Full Text] [Related]
14. [Effects of all-trans retinoic acid on the expression of TGF-beta 1 and COL-I in rat model of peritoneal dialysis].
Wang GH; Tang XH; Ma YL; Gao YC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):575-8. PubMed ID: 18798497
[TBL] [Abstract][Full Text] [Related]
15. The effects of low-dose erythropoiesis-stimulating agents on peritoneal fibrosis induced by chemical peritonitis and on peritoneal tissue MMP-2 and TIMP-2 Levels in rats.
Yildirim A; Ozkan OV; Aslan A; Koseoglu Z; Borazan A
Ren Fail; 2009; 31(7):567-72. PubMed ID: 19839852
[TBL] [Abstract][Full Text] [Related]
16. Impact of rapamycin on peritoneal fibrosis and transport function.
Xu T; Xie JY; Wang WM; Ren H; Chen N
Blood Purif; 2012; 34(1):48-57. PubMed ID: 22922738
[TBL] [Abstract][Full Text] [Related]
17. Development of a peritoneal sclerosis rat model using a continuous-infusion pump.
Komatsu H; Uchiyama K; Tsuchida M; Isoyama N; Matsumura M; Hara T; Fukuda M; Kanaoka Y; Naito K
Perit Dial Int; 2008; 28(6):641-7. PubMed ID: 18981396
[TBL] [Abstract][Full Text] [Related]
18. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S
Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466
[TBL] [Abstract][Full Text] [Related]
19. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats.
Nishino T; Miyazaki M; Abe K; Furusu A; Mishima Y; Harada T; Ozono Y; Koji T; Kohno S
Kidney Int; 2003 Sep; 64(3):887-96. PubMed ID: 12911538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
